Abbott ramping up FreeStyle Libre production following bountiful Q2

"Following a major sales bump in the second quarter of 2019, Abbott Laboratories is planning to significantly ramp up manufacturing for its FreeStyle Libre continuous glucose monitoring system, the company shared during an investor’s call this morning. Specifically, the company highlighted a 72.9% increase in organic sales growth during the three-month period, reaching a worldwide total sales figure of $43 million. What’s more, Abbott CEO and Chairman Miles White said..." Lire la suite